A new drug in clinical trials is showing promise in lowering a key genetic risk factor for heart attacks and ...

Low low-density lipoprotein cholesterol (LDL-C) levels are associated with a reduced risk for dementia, including Alzheimer ...

The Phase II study found that lepodisiran significantly reduced levels of genetically inherited cardiovascular risk factor.

Eli Lilly’s lepodisiran, an investigational siRNA therapy, achieved significant and durable reductions in lipoprotein(a) ...

Eli Lilly has linked lepodisiran to sustained reductions in a cardiovascular disease risk factor for nearly 1.5 years, ...

A single dose of an siRNA molecule reduces elevated lipoprotein(a) — a major, but to date, largely untreatable risk factor ...

Elevated lipoprotein(a) concentrations are associated with atherosclerotic cardiovascular disease. The safety and efficacy of lepodisiran, an extended-duration, small interfering RNA targeting ...

Cutting down on saturated fats, like processed meats, cheese, butter and cakes, is known to help lower cholesterol, and the NHS recommends increasing fruit and vegetable consumption. One fruit, in ...

Heart disease experts are hailing the results of a clinical trial showed a strongly positive performance by a drug that ...

High intake of ultra-processed foods is linked to adverse metabolic health and microstructural brain changes in regions that ...

Matcha is a type of green tea rich in antioxidants and other compounds offering an array of health benefits. Most people can ...

The 5:2 diet effectively reduces weight, BMI, and LDL while improving cardiometabolic health in patients with overweight or obesity, per a meta-analysis.